• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    68 Biggest Movers From Yesterday

    4/5/22 6:37:16 AM ET
    $AERC
    $ARRY
    $ARTW
    $ATER
    Environmental Services
    Utilities
    Miscellaneous manufacturing industries
    Consumer Discretionary
    Get the next $AERC alert in real time by email

    Gainers

    • GBS Inc. (NASDAQ:GBS) jumped 68% to settle at $1.31 on Monday. Zacks Small-Cap Research issued a note on GBS with an $8 valuation.
    • Aterian, Inc. (NASDAQ:ATER) shares surged 46.8% to close at $3.42 on Monday. Aterian said Cynthia Williams has joined the Company's Board of Directors.
    • Protalix BioTherapeutics, Inc. (NYSE:PLX) gained 41.9% to settle at $1.49. Protalix BioTherapeutics and Chiesi Global Rare Diseases, a unit of Chiesi Farmaceutici S.p.A., announced topline data from the BALANCE Phase 3 trial evaluating pegunigalsidase alfa (PRX–102) for Fabry disease.
    • IO Biotech, Inc. (NASDAQ:IOBT) rose 33.2% to settle at $7.55. IO Biotech recently reported cash and equivalents of $211.5 million as of Dec. 31.
    • VirnetX Holding Corp (NYSE:VHC) jumped 31.3% to close at $2.18.
    • Dingdong (Cayman) Limited (NYSE:DDL) surged 28.8% to close at $4.70.
    • BRC Inc. (NYSE:BRCC) gained 28.7% to close at $28.28.
    • Cognition Therapeutics, Inc. (NASDAQ:CGTX) jumped 28.1% to close at $3.33. Cognition Therapeutics recently posted FY21 loss of $3.13 per share.
    • Twitter, Inc. (NYSE:TWTR) shares surged 27.1% to close at $49.97 after Tesla CEO Elon Musk disclosed a 9.2% passive stake in the social media company.
    • Esports Entertainment Group, Inc. (NASDAQ:GMBL) gained 26.4% to close at $0.90. Esports Entertainment, last month, named Damian Mathews as Finance Chief.
    • Jumia Technologies AG (NASDAQ:JMIA) rose 24.7% to close at $11.82 after the company announced it would make its last mile logistics capabilities available to UPS.
    • Lilium N.V. (NASDAQ:LILM) jumped 24.6% to close at $4.86 after the company announced it has begun flight testing at the ATLAS Flight Test Center in Spain.
    • Poema Global Holdings Corp. (NASDAQ:PPGH) rose 23.7% to close at $12.74 following the completion of its business combination with Gogoro.
    • Oragenics, Inc. (NYSE:OGEN) gained 23.6% to close at $0.4170. Oragenics Director Fred Telling acquired a total of 183,838 shares at an average price of $0.36.
    • Yatsen Holding Limited (NYSE:YSG) jumped 23.1% to close at $0.8432.
    • IN8bio, Inc. (NASDAQ:INAB) jumped 22.4% to close at $4.21.
    • Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) gained 22.3% to settle at $2.25.
    • Precipio, Inc. (NASDAQ:PRPO) surged 21.7% to close at $1.68. The company released Q4 results.
    • Liquid Media Group Ltd. (NASDAQ:YVR) gained 21.4% to close at $0.9681.
    • Singularity Future Technology Ltd. (NASDAQ:SGLY) climbed 21.1% to close at $14.97.
    • Red Cat Holdings, Inc. (NASDAQ:RCAT) surged 21% to close at $2.36 after the company announced a drone order for use in Ukraine.
    • Qutoutiao Inc. (NASDAQ:QTT) jumped 20.8% to close at $1.83.
    • LianBio (NASDAQ:LIAN) gained 20.6% to close at $4.50.
    • Tempest Therapeutics, Inc. (NASDAQ:TPST) rose 20.3% to close at $3.85. Tempest Therapeutics posted FY21 loss of $7.47 per share.
    • Futu Holdings Limited (NASDAQ:FUTU) climbed 19.5% to close at $41.35.
    • Regional Health Properties, Inc. (NYSE:RHE) gained 19.4% to close at $4.12.
    • Nuvectis Pharma, Inc. (NASDAQ:NVCT) gained 19.1% to close at $8.36.
    • Xcel Brands, Inc. (NASDAQ:XELB) surged 18.6% to close at $1.66 after the company issued FY21 sales guidance above analyst estimates.
    • Gracell Biotechnologies Inc. (NASDAQ:GRCL) gained 18.3% to close at $2.65 after BTIG initiated coverage on the stock with a Buy rating and a $18 price target.
    • Nuvve Holding Corp. (NASDAQ:NVVE) climbed 17.7% to close at $8.25. Nuvve Holding recently reported Q4 financial results.
    • iQIYI, Inc. (NASDAQ:IQ) jumped 16.7% to settle at $5.58.
    • Bilibili Inc. (NASDAQ:BILI) rose 16.6% to settle at $32.19 after surging 8% on Friday.
    • Perion Network Ltd. (NASDAQ:PERI) gained 15.9% to close at $26.51 after the company reported better-than-expected Q1 financial results.
    • Full Truck Alliance Co. Ltd. (NYSE:YMM) gained 15.8% to close at $8.30.
    • Ollie's Bargain Outlet Holdings, Inc. (NASDAQ:OLLI) climbed 15.7% to close at $49.56 after Wells Fargo upgraded the stock from Equal-Weight to Overweight and announced a $65 price target.
    • iHuman Inc. (NYSE:IH) jumped 15.6% to close at $2.43.
    • Pinduoduo Inc. (NASDAQ:PDD) climbed 15.6% to close at $49.30 following a potential rule change which would allow Chinese companies to share sensitive data with US regulators, thus lowering risk of delisting.
    • RCM Technologies, Inc. (NASDAQ:RCMT) climbed 15% to close at $12.59.
    • Biophytis SA (NASDAQ:BPTS) gained 14.7% to close at $2.57.
    • Inozyme Pharma, Inc. (NASDAQ:INZY) rose 14.1% to close at $4.30 as the company announced preliminary biomarker, safety, and pharmacokinetic (PK) data from the first three patients treated in the Phase 1 portion of its Phase 1/2 trial of INZ-701 in ENPP1 Deficiency.
    • Borr Drilling Limited (NYSE:BORR) climbed 13.3% to close at $4.59.
    • The RealReal, Inc. (NASDAQ:REAL) gained 11.8% to close at $8.07.
    • SPI Energy Co., Ltd. (NASDAQ:SPI) climbed 11.6% to close at $3.17 after reporting record revenue of $162 million for 2021.
    • Context Therapeutics Inc. (NASDAQ:CNTX) shares jumped 10.8% to settle at $2.66 after jumping over 10% on Friday. Context Therapeutics recently posted FY21 net loss of $10.5 million.
    • Array Technologies, Inc. (NASDAQ:ARRY) gained 9% to close at $11.92 after the company announced it will supply advanced tracker technology for "the largest solar + storage project in the US."
    • Clovis Oncology, Inc. (NASDAQ:CLVS) gained 8.8% to close at $2.72.
    • TMC the metals company Inc. (NASDAQ:TMC) climbed 8.6% to close at $2.66.
    • Borqs Technologies, Inc. (NASDAQ:BRQS) gained 8.1% to settle at $0.2270. TDR Capital reported a new stake of 9.9% in Borqs Technologies.

     

    Don’t forget to check out our premarket coverage here .

    Losers

    • Curis, Inc. (NASDAQ:CRIS) shares fell 33.3% to close at $1.62 on Monday. The FDA has placed a partial clinical hold on Curis Inc's TakeAim Leukemia Phase 1/2a study in relapsed or refractory (R/R) acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS).
    • Forge Global Holdings, Inc. (NYSE:FRGE) dipped 21.8% to close at $23.20.
    • GWG Holdings, Inc. (NASDAQ:GWGH) fell 21% to close at $4.22.
    • Snow Lake Resources Ltd. (NASDAQ:LITM) fell 19.3% to close at $8.10.
    • Art's-Way Manufacturing Co., Inc. (NASDAQ:ARTW) dipped 18.5% to close at $4.54. Art's Way Manufacturing announced an 8.9% year-over-year increase in agricultural products segment revenue for Q1.
    • Longeveron Inc. (NASDAQ:LGVN) dropped 17.7% to settle at $12.85. A leading medical journal published study of Longeveron's Phase 1 trial results for Alzheimer's disease.
    • Insignia Systems, Inc. (NASDAQ:ISIG) dropped 16.8% to settle at $10.56.
    • Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) declined 16.8% to close at $1.24. Clarus Therapeutics recently reported Q4 earnings results.
    • Weidai Ltd. (NYSE:WEI) fell 16.1% to close at $1.20 after jumping 29% on Friday.
    • Expion360 Inc. (NASDAQ:XPON) dipped 15.9% to close at $6.67. This new issue opened for trade on Friday of last week.
    • Yunhong CTI Ltd. (NASDAQ:CTIB) dropped 15.8% to close at $1.12.
    • AeroClean Technologies, Inc. (NASDAQ:AERC) fell 15.3% to close at $3.88. AeroClean Technologies recently posted a Q4 loss of $0.13 per share.
    • Iveda Solutions, Inc. (NASDAQ:IVDA) fell 14.3% to close at $3.23. Iveda reported pricing of $8.0 million public offering, uplisting to Nasdaq and reverse stock split.
    • Recruiter.com Group, Inc. (NASDAQ:RCRT) dipped 14.2% to settle at $2.12.
    • Vertex Energy, Inc. (NASDAQ:VTNR) dropped 12.5% to close at $8.67.
    • Matson, Inc. (NASDAQ:MATX) dipped 11.5% to close at $102.25.
    • NextDecade Corporation (NASDAQ:NEXT) fell 11.1% to close at $6.17. Credit Suisse recently downgraded NextDecade from Outperform to Neutral and raised the price target from $3 to $7.5.
    • Rail Vision Ltd. (NASDAQ:RVSN) declined 10.3% to close at $2.44 following Thursday's IPO.
    • Digital World Acquisition Corp. (NASDAQ:DWAC) fell 10% to settle at $56.94 amid Tesla CEO Elon Musk purchasing a 9.2% stake in competitor Twitter.
    • Sharps Compliance Corp. (NASDAQ:SMED) fell 5.9% to close at $5.40. Sharps Compliance named Pat Mulloy as CEO.
    Get the next $AERC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AERC
    $ARRY
    $ARTW
    $ATER

    CompanyDatePrice TargetRatingAnalyst
    PDD Holdings Inc.
    $PDD
    4/17/2026$121.00Neutral → Buy
    Arete
    Bilibili Inc.
    $BILI
    4/13/2026$31.00Equal-Weight → Overweight
    Morgan Stanley
    Ollie's Bargain Outlet Holdings Inc.
    $OLLI
    4/3/2026$130.00Hold → Buy
    Jefferies
    Ollie's Bargain Outlet Holdings Inc.
    $OLLI
    4/2/2026$130.00Hold → Buy
    Jefferies
    Full Truck Alliance Co. Ltd.
    $YMM
    4/1/2026$8.00Underweight → Neutral
    Analyst
    Bilibili Inc.
    $BILI
    3/27/2026$27.00Neutral → Buy
    Citigroup
    PDD Holdings Inc.
    $PDD
    3/27/2026$136.00Neutral → Buy
    Nomura
    Perion Network Ltd.
    $PERI
    3/20/2026$14.00Buy
    Canaccord Genuity
    More analyst ratings

    $AERC
    $ARRY
    $ARTW
    $ATER
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by D Loren Robert W

    4 - XCel Brands, Inc. (0001083220) (Issuer)

    4/22/26 7:24:01 PM ET
    $XELB
    Multi-Sector Companies
    Miscellaneous

    SEC Form 4 filed by Disanto Mark

    4 - XCel Brands, Inc. (0001083220) (Issuer)

    4/22/26 7:22:17 PM ET
    $XELB
    Multi-Sector Companies
    Miscellaneous

    SEC Form 4 filed by Fielding James D

    4 - XCel Brands, Inc. (0001083220) (Issuer)

    4/22/26 7:20:53 PM ET
    $XELB
    Multi-Sector Companies
    Miscellaneous

    $AERC
    $ARRY
    $ARTW
    $ATER
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for RUBRACA issued to CLOVIS ONCOLOGY INC

    Submission status for CLOVIS ONCOLOGY INC's drug RUBRACA (SUPPL-13) with active ingredient RUCAPARIB CAMSYLATE has changed to 'Approval' on 12/21/2022. Application Category: NDA, Application Number: 209115, Application Classification: Efficacy

    12/22/22 4:37:40 AM ET
    $CLVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for RUBRACA issued to CLOVIS ONCOLOGY INC

    Submission status for CLOVIS ONCOLOGY INC's drug RUBRACA (SUPPL-11) with active ingredient RUCAPARIB CAMSYLATE has changed to 'Approval' on 06/10/2022. Application Category: NDA, Application Number: 209115, Application Classification: Efficacy

    6/13/22 2:20:18 PM ET
    $CLVS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AERC
    $ARRY
    $ARTW
    $ATER
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Taslitz Steven bought $223,500 worth of shares (300,000 units at $0.74), increasing direct ownership by 33% to 601,184 units (SEC Form 4)

    4 - BRC Inc. (0001891101) (Issuer)

    3/9/26 5:08:04 PM ET
    $BRCC
    Beverages (Production/Distribution)
    Consumer Staples

    Amendment: Chief Operating Officer Sabet Ahmed Zaki bought $468 worth of shares (20 units at $23.40), increasing direct ownership by 2% to 1,015 units (SEC Form 4)

    4/A - Precipio, Inc. (0001043961) (Issuer)

    1/20/26 4:22:27 PM ET
    $PRPO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: Chief Operating Officer Sabet Ahmed Zaki bought $488 worth of shares (25 units at $19.50), increasing direct ownership by 3% to 995 units (SEC Form 4)

    4/A - Precipio, Inc. (0001043961) (Issuer)

    1/20/26 4:21:46 PM ET
    $PRPO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $AERC
    $ARRY
    $ARTW
    $ATER
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    PDD Holdings upgraded by Arete with a new price target

    Arete upgraded PDD Holdings from Neutral to Buy and set a new price target of $121.00

    4/17/26 9:26:04 AM ET
    $PDD
    EDP Services
    Technology

    Bilibili upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded Bilibili from Equal-Weight to Overweight and set a new price target of $31.00

    4/13/26 8:37:56 AM ET
    $BILI
    EDP Services
    Technology

    Ollie’s Bargain Outlet upgraded by Jefferies with a new price target

    Jefferies upgraded Ollie’s Bargain Outlet from Hold to Buy and set a new price target of $130.00

    4/3/26 10:44:58 AM ET
    $OLLI
    Department/Specialty Retail Stores
    Consumer Discretionary

    $AERC
    $ARRY
    $ARTW
    $ATER
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    MATSON ANNOUNCES ADDITION OF 3 MILLION SHARES TO EXISTING SHARE REPURCHASE PROGRAM AND QUARTERLY DIVIDEND OF $0.36 PER SHARE

    HONOLULU, April 23, 2026 /PRNewswire/ -- The Board of Directors of Matson, Inc. (NYSE:MATX), a leading U.S. carrier in the Pacific, approved adding three million shares to its existing share repurchase program and extending the program to December 31, 2029.  As of April 23, 2026, the existing share repurchase program had approximately 0.7 million shares remaining.  The Board also declared a second quarter dividend of $0.36 per common share.  The dividend will be paid on June 4, 2026 to all shareholders of record as of the close of business on May 7, 2026. "We are pleased to anno

    4/23/26 6:45:00 PM ET
    $MATX
    Marine Transportation
    Consumer Discretionary

    A $550 Billion Opportunity: Drones-as-a-Service Emerges as Defense's Next Growth Engine

    Governments are accelerating investments in scalable autonomous drone operations without the burden of fleet ownershipMarket News Updates News Commentary CounterNEW YORK, April 23, 2026 /CNW/ -- Drones-as-a-Service (DaaS) is quickly becoming a major shift in how military and defense organizations actually use drone technology in the field. Instead of spending heavily to purchase and maintain their own fleets, agencies can now tap into drone capabilities like aerial surveillance, mapping, logistics delivery, and ISR (intelligence, surveillance, and reconnaissance) whenever they're needed. It works a lot like a cloud subscription model—giving operators access to the latest hardware, AI-powered

    4/23/26 9:00:00 AM ET
    $PRZO
    $RCAT
    $UAVS
    Military/Government/Technical
    Industrials
    Computer Software: Prepackaged Software
    Technology

    Moomoo Launches Agentic Investing with Introduction of Moomoo API Skills

    JERSEY CITY, N.J., April 23, 2026 (GLOBE NEWSWIRE) -- Moomoo, a leading global investment and trading platform, today announced the launch of Moomoo API Skills, an innovative capability designed to lead retail investors into the era of agentic investing.* By enabling investors to connect their personal AI agents directly to moomoo's professional-grade infrastructure, the platform transforms natural language input into structured, executable investment strategies. Redefining the Investing Journey for All InvestorsFor years, algo trading has largely been accessible only to users with strong technical and coding expertise. By eliminating the need for coding, Moomoo API Skills empowers user

    4/23/26 9:00:00 AM ET
    $FUTU
    Investment Bankers/Brokers/Service
    Finance

    $AERC
    $ARRY
    $ARTW
    $ATER
    SEC Filings

    View All

    SEC Form DEF 14A filed by NextDecade Corporation

    DEF 14A - NextDecade Corp (0001612720) (Filer)

    4/23/26 5:17:57 PM ET
    $NEXT
    Oil & Gas Production
    Utilities

    Amendment: SEC Form SCHEDULE 13G/A filed by Ollie's Bargain Outlet Holdings Inc.

    SCHEDULE 13G/A - Ollie's Bargain Outlet Holdings, Inc. (0001639300) (Subject)

    4/23/26 12:38:54 PM ET
    $OLLI
    Department/Specialty Retail Stores
    Consumer Discretionary

    SEC Form 6-K filed by Perion Network Ltd.

    6-K - Perion Network Ltd. (0001338940) (Filer)

    4/23/26 6:40:16 AM ET
    $PERI
    EDP Services
    Technology

    $AERC
    $ARRY
    $ARTW
    $ATER
    Financials

    Live finance-specific insights

    View All

    MATSON ANNOUNCES ADDITION OF 3 MILLION SHARES TO EXISTING SHARE REPURCHASE PROGRAM AND QUARTERLY DIVIDEND OF $0.36 PER SHARE

    HONOLULU, April 23, 2026 /PRNewswire/ -- The Board of Directors of Matson, Inc. (NYSE:MATX), a leading U.S. carrier in the Pacific, approved adding three million shares to its existing share repurchase program and extending the program to December 31, 2029.  As of April 23, 2026, the existing share repurchase program had approximately 0.7 million shares remaining.  The Board also declared a second quarter dividend of $0.36 per common share.  The dividend will be paid on June 4, 2026 to all shareholders of record as of the close of business on May 7, 2026. "We are pleased to anno

    4/23/26 6:45:00 PM ET
    $MATX
    Marine Transportation
    Consumer Discretionary

    The Longevity Trade Is No Longer a Buzzword — It's a $120 Billion Market, and the FDA Just Cleared the First Cellular Rejuvenation Trial

    Issued on behalf of Avaí Bio, Inc. Companies mentioned in this commentary include: Avaí Bio, Inc. (OTCQB:AVAI), Eli Lilly and Company (NYSE:LLY), Novo Nordisk A/S (NYSE:NVO), Viking Therapeutics, Inc. (NASDAQ:VKTX), Longeveron Inc. (NASDAQ:LGVN). Key Takeaways: The global anti-aging market generated more than $85 billion in 2025 and is projected to approach $120 billion by 2030, with private investment in longevity science more than doubling to $8.49 billion across 325 deals last year.The U.S. FDA approved 50 new drugs in 2024 and 46 in 2025 — including what researchers are calling the first drug class of "longevity therapeutics" — while big pharma spent more than $65 billion acquiring bi

    4/23/26 6:15:00 AM ET
    $LGVN
    $LLY
    $NVO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    iQIYI to Report First Quarter 2026 Financial Results on May 18, 2026

    BEIJING, April 23, 2026 (GLOBE NEWSWIRE) -- iQIYI, Inc. (NASDAQ:IQ) ("iQIYI" or the "Company"), a leading provider of online entertainment video services in China, today announced that it will report its financial results for the first quarter ended March 31, 2026 before the U.S. market opens on May 18, 2026. iQIYI's management will hold an earnings conference call at 7:00 AM on May 18, 2026, U.S. Eastern Time (7:00 PM on May 18, 2026, Beijing Time). Please register in advance of the conference using the link provided below. Upon registering, you will be provided with participant dial-in numbers, passcode and unique access PIN by a calendar invite. Participant Online Registration: https

    4/23/26 5:00:00 AM ET
    $IQ
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $AERC
    $ARRY
    $ARTW
    $ATER
    Leadership Updates

    Live Leadership Updates

    View All

    As the Counter-Drone Era Goes Mainstream, This Nasdaq AI Defense Stock Just Landed a World Cup Deployment Order

    Issued on behalf of VisionWave Holdings, Inc. Companies mentioned in this commentary include: VisionWave Holdings, Inc. (NASDAQ:VWAV), Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS), Red Cat Holdings, Inc. (NASDAQ:RCAT), Ondas Holdings Inc. (NASDAQ:ONDS), Unusual Machines, Inc. (NYSE:UMAC). Key Takeaways: The global counter-drone market has become one of the fastest-growing niches in defense, driven by the proliferation of cheap weaponized UAS across battlefields and public events.VisionWave Holdings (NASDAQ:VWAV) presented its three-pillar technology platform — VisionRF™, Stratum™, and qSpeed™ — to more than 580 investors at the 91st Emerging Growth Conference on April 2,

    4/16/26 9:00:00 AM ET
    $KTOS
    $ONDS
    $RCAT
    Military/Government/Technical
    Industrials
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Tempest Appoints Andrew Fang, Ph.D., as Head of Business Development to Advance Strategic Partnerships and Global Licensing Efforts

    Adds dedicated business development leadership to support Tempest's strategic prioritiesWill lead China outreach and cross-border partnership effortsTo support ongoing partnering discussions for Phase 3-ready amezalpat program, including potential China development opportunities BRISBANE, Calif., April 14, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (NASDAQ:TPST) ("Tempest"), a clinical-stage biotechnology company developing a pipeline of advanced CAR-T cell therapy product candidates to treat cancer, today announced the appointment of Andrew Fang, Ph.D., as Head of Business Development. Dr. Fang will lead Tempest's global business development efforts, including strategic partners

    4/14/26 8:00:00 AM ET
    $TPST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Neogen® Corporation Announces Appointment of Jennifer Evans Stacey as Chief Legal & Compliance Officer and Board Secretary

    Neogen Corporation (NASDAQ:NEOG), an innovative leader in food safety solutions, today announced the appointment of Jennifer Evans Stacey as Chief Legal & Compliance Officer and Board Secretary. Ms. Stacey is an accomplished chief legal and compliance officer and board secretary with extensive experience in the life sciences industry. She has served more than 10 years as a public company chief legal and compliance officer and board secretary, as well as five years as a public company board member. Over her more than 25-year career, she has led legal, compliance, government relations, corporate communications and human resources functions, operating in complex, fast-moving environments.

    4/8/26 8:00:00 AM ET
    $CNTX
    $NEOG
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: In Vitro & In Vivo Diagnostic Substances

    $AERC
    $ARRY
    $ARTW
    $ATER
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Inozyme Pharma Inc.

    SC 13G - Inozyme Pharma, Inc. (0001693011) (Subject)

    12/9/24 4:14:49 PM ET
    $INZY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Red Cat Holdings Inc.

    SC 13G/A - Red Cat Holdings, Inc. (0000748268) (Subject)

    12/6/24 4:32:04 PM ET
    $RCAT
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by iQIYI Inc.

    SC 13D/A - iQIYI, Inc. (0001722608) (Subject)

    12/4/24 8:11:53 AM ET
    $IQ
    Consumer Electronics/Video Chains
    Consumer Discretionary